← Human Trials & Peer-Reviewed Studies

A randomized cross-over short-term study on the short-term effects of a zinc-lactate containing mouthwash against oral malodour.

Plain-language guide to PMID 30523908 (2019): double-blind randomized controlled trial of Vitamin D, K2, Magnesium and Zinc.

Key Facts

PMID
30523908
Journal
Journal of breath research
Year
2019
Study type
Randomized Controlled Trial
Authors
Jervøe-Storm PM et al. (3 authors)
DOI
10.1088/1752-7163/aaf401

What This Study Did, in Plain Language

What Was Tested

The paper reports a study of Vitamin D, K2, Magnesium and Zinc, published as a randomized controlled trial.

This randomized controlled cross-over-design-study investigated short-term effects on oral malodour of a zinc-lactate-containing mouthwash.

Who Took Part

The age groups tagged for this paper are young adults, adults and middle-aged adults, both men and women.

Sixteen subjects (18-65 years) with an organoleptic score (OLS) ≥2 were included.

Subject's perception was investigated with a visual-analogue-scale.

How the Study Was Run

The researchers set it up as a randomized, double-blind and crossover study.

The participants were allocated by chance, so the Vitamin D, K2, Magnesium and Zinc group and the comparison group should start out alike.

As a double-blind Vitamin D, K2, Magnesium and Zinc study, the assignments were hidden from both participants and investigators until the end.

Each person switched between Vitamin D, K2, Magnesium and Zinc and the comparison at some point, usually with a gap in between.

Each formulation was evaluated by two blinded examiners comparing OLS and three volatile-sulphur-compounds (VSC; H2S (hydrogen sulphide), CH3SH (methyl mercaptan) and (CH3)2S (dimethyl sulphide)) before, 1 and 3 h after rinsing.

What Was Measured

Topics PubMed links to this paper include Dental Plaque, Halitosis, Hydrogen Sulfide, Lactates, Mouth, Mouthwashes and Sensation.

What This Means in Plain Language

The paper is a randomized, double-blind and crossover study of Vitamin D, K2, Magnesium and Zinc.

Results are reported in around 4 sentences of the abstract; we leave them to the paper itself rather than summarise them.

The publication is from 2019 (Journal of breath research), a journal based in England.

More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.

Our Notes on the Compound

Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.

Related Pages

Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.